Hansa Biopharma: increase in number of shares and votes

The information in the press release is information that Hansa Biopharma AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons above, on May 3, 2024 at 08:00 (CEST). The information in the press release is information that Hansa Biopharma AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the...

The information in the press release is information that Hansa Biopharma AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons above, on May 3, 2024 at 08:00 (CEST).

Contacts for more information:

Evan Ballantyne, Chief Financial Officer
ir@hansabiopharma.com 

Stephanie Kenney, VP Global Corporate Affairs
media@hansabiopharma.com 

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma--increase-in-number-of-shares-and-votes,c3972696

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/hansa-biopharma-increase-in-number-of-shares-and-votes-302135462.html